OBJECTIVE: Elderly patients with head and neck cancer often receive non-standard treatment for reasons other than comorbidity. In this prospective study we investigated how elderly patients fare 1 year after treatment in comparison with their younger counterparts. MATERIAL AND METHODS: Seventy patients aged 45-60 years and 51 patients aged > or = 70 years with cancer of the oral cavity, pharynx (stage II-IV) or larynx (stage III-IV) participated in the study before treatment and 1 year later. Each patient was interviewed and given a questionnaire concerning physical functioning, social contacts, depressive symptoms, satisfaction with treatment and future expectations. RESULTS: At 12 months, patients in both age groups reported significantly more depressive symptoms and less social support than before treatment, and their Karnofsky Performance Score was lower. However, there were no differences between elderly and younger patients. Approximately 90% of those in both age groups said that they would choose the same treatment again, and there was no age difference regarding the impact of treatment or expectations for the future. CONCLUSION: This study shows that the impact of treatment on quality of life did not differ between elderly and younger patients with head and neck cancer. Therefore, standard treatment should be considered in elderly patients if no severe contraindications exist.
OBJECTIVE: Elderly patients with head and neck cancer often receive non-standard treatment for reasons other than comorbidity. In this prospective study we investigated how elderly patients fare 1 year after treatment in comparison with their younger counterparts. MATERIAL AND METHODS: Seventy patients aged 45-60 years and 51 patients aged > or = 70 years with cancer of the oral cavity, pharynx (stage II-IV) or larynx (stage III-IV) participated in the study before treatment and 1 year later. Each patient was interviewed and given a questionnaire concerning physical functioning, social contacts, depressive symptoms, satisfaction with treatment and future expectations. RESULTS: At 12 months, patients in both age groups reported significantly more depressive symptoms and less social support than before treatment, and their Karnofsky Performance Score was lower. However, there were no differences between elderly and younger patients. Approximately 90% of those in both age groups said that they would choose the same treatment again, and there was no age difference regarding the impact of treatment or expectations for the future. CONCLUSION: This study shows that the impact of treatment on quality of life did not differ between elderly and younger patients with head and neck cancer. Therefore, standard treatment should be considered in elderly patients if no severe contraindications exist.
Authors: Christian J Nelson; Christina Cho; Alexandra R Berk; Jimmie Holland; Andrew J Roth Journal: J Clin Oncol Date: 2009-12-07 Impact factor: 44.544
Authors: Kristin M Kilbourn; Derek Anderson; Allison Costenaro; Kate Lusczakoski; Evelinn Borrayo; David Raben Journal: Support Care Cancer Date: 2012-06-15 Impact factor: 3.603
Authors: Thomas T A Peters; Sophie F Post; Boukje A C van Dijk; Jan L N Roodenburg; Bernard F A M van der Laan; Paul M N Werker; Gyorgy B Halmos Journal: Eur Arch Otorhinolaryngol Date: 2014-09-13 Impact factor: 2.503
Authors: Thomas F Barrett; Angela L Mazul; Katelyn O Stepan; C Burton Wood; Randall C Paniello; Jose P Zevallos; Sean Massa; Ryan S Jackson; Nicole C Schmitt; Joseph Zenga; Stephen Y Kang; Patrik Pipkorn; Jason T Rich; Sidharth V Puram Journal: Oral Oncol Date: 2021-05-12 Impact factor: 5.972
Authors: Laura H A Korsten; Femke Jansen; Ben J F de Haan; Danielle Sent; Pim Cuijpers; C René Leemans; Irma M Verdonck-de Leeuw Journal: Psychooncology Date: 2019-05-09 Impact factor: 3.894
Authors: Caroline M Speksnijder; Petra J M Lankhorst; Remco de Bree; Anton F J de Haan; Ron Koole; Matthias A W Merkx Journal: Support Care Cancer Date: 2020-10-01 Impact factor: 3.603